celecoxib has been researched along with Carcinoma, Squamous Cell of Head and Neck in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-dependent cardiac toxicity limits long-term use of celecoxib." | 5.42 | The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma. ( Chen, Z; Hu, R; Huang, Y; Jiang, H; Jiang, J; Xu, H; Yan, J; Yang, Y; Zhang, Y, 2015) |
| "Platinum-resistant oral cancer has a dismal outcome with limited treatment options." | 2.90 | Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. ( Abraham, G; Banavali, S; Bhattacharjee, A; Chandrasekharan, A; Das, S; Dhumal, S; DSouza, H; Gota, V; Joshi, A; Kashyap, L; Kumar, S; Mahajan, A; Mahimkar, M; Menon, N; Mukadam, S; Nawale, K; Noronha, V; Pandey, M; Patil, VM; Prabhash, K; Sable, N; Simha, V; Solanki, B; Srinivas, S; Talreja, V, 2019) |
| " Dose-dependent cardiac toxicity limits long-term use of celecoxib." | 1.42 | The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma. ( Chen, Z; Hu, R; Huang, Y; Jiang, H; Jiang, J; Xu, H; Yan, J; Yang, Y; Zhang, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kamal, MV | 1 |
| Rao, M | 1 |
| Damerla, RR | 1 |
| Pai, A | 1 |
| Sharan, K | 1 |
| Palod, A | 1 |
| Shetty, PS | 1 |
| Usman, N | 1 |
| Kumar, NAN | 1 |
| Patil, VM | 1 |
| Noronha, V | 1 |
| Joshi, A | 1 |
| Dhumal, S | 1 |
| Mahimkar, M | 1 |
| Bhattacharjee, A | 1 |
| Gota, V | 1 |
| Pandey, M | 1 |
| Menon, N | 1 |
| Mahajan, A | 1 |
| Sable, N | 1 |
| Kumar, S | 1 |
| Nawale, K | 1 |
| Mukadam, S | 1 |
| Solanki, B | 1 |
| Das, S | 1 |
| Simha, V | 1 |
| Abraham, G | 1 |
| Chandrasekharan, A | 1 |
| Talreja, V | 1 |
| DSouza, H | 1 |
| Srinivas, S | 1 |
| Kashyap, L | 1 |
| Banavali, S | 1 |
| Prabhash, K | 1 |
| Velmurugan, BK | 1 |
| Hua, CH | 1 |
| Tsai, MH | 1 |
| Lee, CP | 1 |
| Chung, CM | 1 |
| Ko, YC | 1 |
| Gehrke, T | 1 |
| Scherzad, A | 1 |
| Hackenberg, S | 1 |
| Ickrath, P | 1 |
| Schendzielorz, P | 1 |
| Hagen, R | 1 |
| Kleinsasser, N | 1 |
| Qian, M | 1 |
| Qian, D | 1 |
| Jing, H | 1 |
| Li, Y | 1 |
| Ma, C | 1 |
| Zhou, Y | 1 |
| Yang, Y | 1 |
| Yan, J | 1 |
| Huang, Y | 1 |
| Xu, H | 1 |
| Zhang, Y | 1 |
| Hu, R | 1 |
| Jiang, J | 1 |
| Chen, Z | 1 |
| Jiang, H | 1 |
1 review available for celecoxib and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
A Mechanistic Review of Methotrexate and Celecoxib as a Potential Metronomic Chemotherapy for Oral Squamous Cell Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Celecoxib; Head and Neck N | 2023 |
1 trial available for celecoxib and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.
Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; | 2019 |
4 other studies available for celecoxib and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells.
Topics: Cadherins; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2020 |
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell | 2017 |
Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Ce | 2014 |
The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Survival; Cetuxim | 2015 |